News
-
-
COMMUNIQUÉ DE PRESSE
Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
Redcare Pharmacy N.V. achieved record growth with 49% increase in sales and 3.7pp rise in adj. EBITDA margin in 2023. Full-year guidance met. Details on continued growth and positive margins for 2024 outlined by CEO Olaf Heinrich -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
Redcare Pharmacy implements internal succession plan for CCO and CIO positions to ensure continuity and stability. Long-standing managers Dirk Brüse and Lode Fastré to take over. Founders to support in advisory roles until 2026 -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
Redcare Pharmacy implements internal succession plan following the early departure of CCO Stephan Weber and CIO Marc Fischer. New appointments planned for the Annual General Meeting on 17 April 2024 -
-
COMMUNIQUÉ DE PRESSE
Redcare Pharmacy continues to successfully grow fast in all its markets.
